Product Description
L-3,4-Dihydroxyphenylalanine (L-DOPA), an antiParkinsonian agent, is the natural isomer of the immediate precursor to dopamine. L-DOPA is the product of the hydroxylation of L-tyrosine by tyrosine hydroxylase in brain and in adrenal medulla.
Application Notes
L-beta-3,4-Dihydroxyphenylalanine used in treatment of Parkinsonism. Also an inhibitor of tyrosine aminotransferase.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Treatment of Parkinsonism | Inhibitor of tyrosine aminotransferase
Specifications
| SKU | 0210157825 |
| Alternate Names | 3-(3,4-Dihydroxyphenyl)-L-alanine; L-3-Hydroxytyrosine; L-DOPA; Levodopa |
| Application Notes | L-beta-3,4-Dihydroxyphenylalanine used in treatment of Parkinsonism. Also an inhibitor of tyrosine aminotransferase. |
| Base Catalog Number | 10157825 |
| Beilstein Registry Number | 2215169 |
| Biochemical Physiological Actions | Natural isomer of the immediate precursor of dopamine; product of tyrosine hydroxylase |
| CAS # | 59-92-7 |
| EC Number | 200-445-2 |
| Extinction Coefficient | EmM= 2.63 (280 nm); 6.17 (220.5 nm) (Lit.) |
| Format | Powder |
| Hazard Statements | H302-H315-H319-H335 |
| Melting Point | 276-278 °C(Lit.) |
| Molecular Formula | C9H11NO4 |
| Molecular Weight | 197.19 |
| Pack Size | 25 g |
| Personal Protective Equipment | Dust mask , Eyeshields, Gloves |
| pKa | pKa(25 °C): 2.3, 8.7, 9.7, 13.4 (Lit.) |
| Purity | ≥99.0% |
| RTECS Number | AY5600000 |
| Safety Symbol | GHS07 |
| Solubility | Soluble in 0.5M HCl(50 mg/mL). |
| Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
Documents
